Babson Diagnostics Closes $13.7 Million Series A to Democratize Diagnostic Blood Testing
Sep 24, 2020•almost 5 years ago
Amount Raised
$13 Million
Round Type
series a
Description
Babson Diagnostics (Babson), a transformative medical technology company, announced today it closed $13.7 million in cumulative Series A funding, led by Siemens Healthineers, Prism Ventures, Genesis Merchant Capital, and Lago Consulting Group.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech